Renal Cancer - Results from #8340

Histologic variants of renal cell carcinoma: Does tumor type influence outcome? - Abstract August 2, 2012

Urological cancer metastasis to the brain: When should we resect? - Abstract August 1, 2012

Can the Kattan nomogram still accurately predict prognosis in renal cell carcinoma using the revised 2010 tumor-nodes-metastasis reclassification? - Abstract August 1, 2012

Correlation between surgical modality and clinicopathologic characteristics for ureteral transitional cell carcinoma - Abstract August 1, 2012

Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome - Abstract July 31, 2012

Chronic kidney disease after nephrectomy in patients with small renal masses: A retrospective observational analysis - Abstract July 31, 2012

Renal vein leiomyosarcoma: imaging and clinical features of a renal cell carcinoma mimic - Abstract July 30, 2012

Treatment selection in metastatic renal cell carcinoma: Expert consensus - Abstract July 30, 2012

Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus - Abstract July 28, 2012

Pancreatic resection for metastases from renal cancer: Long term outcome after surgery and immunotherapy approach - single center experience - Abstract July 27, 2012

Renal lesions with low R.E.N.A.L nephrometry score are associated with more indolent renal cell carcinomas (RCCs) or benign histology: Findings in an Australian cohort - Abstract July 26, 2012

Sunitinib malate - Abstract July 26, 2012

Integration of laparoscopic partial nephrectomy into an Australian public hospital: Three-year follow-up of our initial 50 cases - Abstract July 25, 2012

Characterization of small renal masses less than 4 cm with Quadriphasic Multidetector Helical Computed Tomography: Differentiation of benign and malignant lesions - Abstract July 25, 2012

Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VE July 24, 2012

Role of immunohistochemistry in diagnosing renal neoplasms: When is it really useful? - Abstract July 24, 2012

Robotic partial nephrectomy in a morbidly obese patient: A case report - Abstract July 23, 2012

Adult Wilms tumor with spinal metastases - Abstract July 23, 2012

Emerging critical role of molecular testing in diagnostic genitourinary pathology - Abstract July 23, 2012

Renal cell carcinoma with clear cell and papillary features - Abstract July 23, 2012

Page 418 of 456